These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 91724)

  • 1. MS and EAE.
    Lancet; 1979 Nov; 2(8150):1001-2. PubMed ID: 91724
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of the immune reaction in multiple sclerosis might be achieved by intravenous injections of myelin basic protein, concomitant with the administration of an immunosuppressant and a corticosteroid.
    Eidinoff H
    Med Hypotheses; 1988 Apr; 25(4):219-22. PubMed ID: 2452965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.
    Steinman L; Zamvil SS
    Trends Immunol; 2005 Nov; 26(11):565-71. PubMed ID: 16153891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis.
    Mackay IR; Carnegie PR; Coates AS
    Clin Exp Immunol; 1973 Dec; 15(4):471-82. PubMed ID: 4130537
    [No Abstract]   [Full Text] [Related]  

  • 5. LT/EAE and the MS quest. Going to the dogs and rats to study the patient.
    Paterson PY
    Cell Immunol; 1983 Nov; 82(1):55-74. PubMed ID: 6196130
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
    Stuerzebecher S; Martin R
    Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenge: how good a model of MS is EAE today?
    Alvord EC
    Prog Clin Biol Res; 1984; 146():3-5. PubMed ID: 6201903
    [No Abstract]   [Full Text] [Related]  

  • 8. [Multiple sclerosis and the immune system. Progress and unsolved problems].
    Mertin J
    Med Klin; 1978 Dec; 73(50):1752-67. PubMed ID: 82904
    [No Abstract]   [Full Text] [Related]  

  • 9. Oligoclonal IgG band patterns in chronic relapsing EAE and MS.
    Mehta PD; Patrick BA; Wisniewski HM
    Prog Clin Biol Res; 1984; 146():341-6. PubMed ID: 6718426
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multiple sclerosis and experimental autoimmune encephalomyelitis].
    Béraud-Juven E
    Rev Prat; 1994 Jan; 44(1):69-74. PubMed ID: 8178062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelin basic protein and multiple sclerosis.
    Whitaker JN
    Ital J Neurol Sci; 1983 Jun; 4(2):153-7. PubMed ID: 6194137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin basic protein: what role in MS?
    JAMA; 1978 Jul; 240(1):15. PubMed ID: 77920
    [No Abstract]   [Full Text] [Related]  

  • 13. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
    Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
    Holmøy T
    Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effect of pregnancy on MS and EAE.
    Abramsky O; Lubetzki-Korn I; Evron S; Brenner T
    Prog Clin Biol Res; 1984; 146():399-406. PubMed ID: 6201909
    [No Abstract]   [Full Text] [Related]  

  • 16. A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses.
    Huntington ND; Tomioka R; Clavarino C; Chow AM; Liñares D; Maña P; Rossjohn J; Cachero TG; Qian F; Kalled SL; Bernard CC; Reid HH
    Int Immunol; 2006 Oct; 18(10):1473-85. PubMed ID: 16914508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of factors in chronic relapsing EAE and MS sera which induce myelinotoxicity and cellular changes in organ culture.
    Bradbury K; Suckling AJ
    Prog Clin Biol Res; 1984; 146():193-8. PubMed ID: 6201890
    [No Abstract]   [Full Text] [Related]  

  • 18. [Heat shock protein 105 in multiple sclerosis].
    Minohara M
    Nihon Rinsho; 2003 Aug; 61(8):1317-22. PubMed ID: 12962017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
    Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells.
    Ji Q; Goverman J
    Ann N Y Acad Sci; 2007 Apr; 1103():157-66. PubMed ID: 17376824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.